Alignment Health Plan Earns 2026 Excellence Award, In Top 1.6% of MAPD Plans
Alignment Health Plan’s Medicare Advantage prescription drug plan secured the 2026 Excellence in Quality Award, earning a perfect 5-star rating on all five PQA medication measures and a 4.5-star Part D summary rating. The plan was one of only four MAPDs recognized—just 1.6% of the 613 eligible contracts.
1. Excellence Award Recognition
This year, Alignment Health Plan was one of four Medicare Advantage Prescription Drug plans recognized for outstanding quality, representing just 1.6% of the 613 eligible contracts evaluated.
2. Award Criteria and Performance
To earn the 2026 Excellence in Quality Award, its MAPD plan secured at least a 4.5-star Part D summary rating and perfect 5-star marks on all five PQA medication measures covering diabetes, hypertension, cholesterol adherence, medication therapy management completion, and statin use in diabetic patients.
3. Historical Achievements and Strategic Impact
This marks the seventh PQA quality award for Alignment’s MAPD offerings and underscores its ongoing investment in data-driven pharmacy programs and personalized support aimed at reducing medication risks and enhancing senior care.